High normal blood pressure in early pregnancy also contribute to early onset preeclampsia and severe preeclampsia
Authors:
- 27 November 2017
- journal article
- research article
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 40 (6) , 539-546
Abstract
Objective: This study was to evaluate effects of high normal blood pressure (HNBP) in early pregnancy on total preeclampsia, early preeclampsia, and severe preeclampsia. Methods: We conducted a multicenter, national representative retrospective cohort study. HNBP was defined as systolic blood pressure between 130 and 140 mmHg or diastolic blood pressure between 85 and 90 mmHg. We used multivariable logistic regression to examine the associations of HNBP and the risks of above three types of preeclampsia. Results: We included 58 054 women who were normotensive and nulliparous in early pregnancy. 4 809 (8.3%) fulfilled the definition of having HNBP, 16 682 (28.7%) were in normal blood pressure group, and 36 563 (63.0%) were in optimal blood pressure group. The incidence rates of total preeclampsia, early preeclampsia, and severe preeclampsia were 2.1% (1 217), 0.8% (491), and 1.4% (814), respectively. Compared to having optimal blood pressure, women with HNBP had significantly higher odds of total preeclampsia (odds ratio (OR) = 4.028, 95% confidence interval (CI) 3.377, 4.804), severe preeclampsia (OR = 3.542, 95% CI 2.851, 4.400), and early preeclampsia (OR = 8.163, 95% CI 6.219, 10.715). Our restricted cubic spline results supported the dose–response relationship between continuous blood pressure and the odds ratio of three types of preeclampsia. The fraction of early preeclampsia associated with prehypertension was 58.6%, which was higher than those of total preeclampsia (42.2%) or severe preeclampsia (40.5%). Conclusion: Women in early pregnancy with HNBP more likely develop total preeclampsia, early preeclampsia and severe preeclampsia, compared to those with optimal blood pressure. HNBP contribute more to early preeclampsia than severe preeclampsia. Our study provided robust epidemiological evidences for monitoring HNBP in early pregnancy to reduce the risks of preeclampsia.Keywords
Funding Information
- National Natural Science Foundation of China (no. 81402689)
- Beijing Municipal Science& Techology (Z151100004015182)
This publication has 29 references indexed in Scilit:
- Serum placental growth factor as a predictor of early onset preeclampsia in overweight/obese pregnant womenJournal of the American Society of Hypertension, 2013
- Maternal Cardiovascular Impairment in Pregnancies Complicated by Severe Fetal Growth RestrictionHypertension, 2012
- Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohortBMJ, 2011
- Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsiaJournal of Perinatal Medicine, 2011
- Normal and High-Normal Blood Pressures, but Not Body Mass Index, Are Risk Factors for the Subsequent Occurrence of Both Preeclampsia and Gestational Hypertension: A Retrospective Cohort StudyHypertension Research, 2006
- Pre-eclampsiaThe Lancet, 2005
- Height and risk of severe pre-eclampsia. A study within the Danish National Birth CohortInternational Journal of Epidemiology, 2004
- Is pre‐eclampsia more than one disease?BJOG: An International Journal of Obstetrics & Gynaecology, 2004
- Heterogeneous causes constituting the single syndrome of preeclampsia: A hypothesis and its implicationsAmerican Journal of Obstetrics and Gynecology, 1996
- Perinatal morbidity in chronic hypertensionBJOG: An International Journal of Obstetrics & Gynaecology, 1996